X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q2 2022 Earnings Conference Call August 4, 2022 8:30 AM ET Company Participants Dan Ferry - LifeSci Advisors, IR Dr. Paula Ragan - Chief Executive Officer Adam Mostafa - Chief Financial Officer Art Taveras - Chief Scientific Officer Diego Cadavid - Chief Medical Officer Mary DiBiase - Chief Operating Officer Conference Call Participants Stephen Willey - Stifel Eva Privitera - Cowen Mayank Mamtani - B. Riley Securities Arthur He - H.C. Wainwright Operator Greetings. And ...

Corporate Overview August 2022 Forward-Looking Statements 2 This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements may be identified by the words "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "project," "potential," "continue," "target," or other similar terms or expressions that concern X4's expectations, strategy, plans, or intenti ...

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q1 2022 Earnings Conference Call May 12, 2022 8:30 AM ET Company Participants Glenn Schulman - Vice President, Investor Relations and Corporate Communications Paula Ragan - President and Chief Executive Officer Adam Mostafa - Chief Financial Officer Diego Cadavid - Chief Medical Officer Arthur Taveras - Chief Scientific Officer Conference Call Participants Marc Frahm - Cowen & Company William Wood - B. Riley Securities Trevor Howard - Oppenheimer Zegbeh Jallah - ROTH ...

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q4 2021 Earnings Conference Call March 17, 2022 8:30 AM ET Company Participants Glenn Schulman - Vice President, Investor Relations & Corporate Communications Paula Ragan - President & Chief Executive Officer Adam Mostafa - Chief Financial Officer Diego Cadavid - Chief Medical Officer Arthur Taveras - Chief Scientific Officer Conference Call Participants Stephen Willey - Stifel Marc Frahm - Cowen & Company Mayank Mamtani - B. Riley Securities Arthur He - H.C. Wainwrigh ...

Investor Presentation March 2022 Forward-Looking Statements 2 This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements may be identified by the words "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "project," "potential," "continue," "target," or other similar terms or expressions that concern X4's expectations, strategy, plans, or inten ...

Investor Presentation November 2021 Forward-Looking Statements 2 This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements may be identified by the words "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "project," "potential," "continue," "target," or other similar terms or expressions that concern X4's expectations, strategy, plans, or in ...

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q3 2021 Earnings Conference Call November 4, 2021 9:05 AM ET Company Participants Dan Ferry - LifeSci Advisors Paula Ragan - Chief Executive Officer Adam Mostafa - Chief Financial Officer Art Taveras - Chief Scientific Officer Diego Cadavid - Chief Medical Officer Conference Call Participants Zegbeh Jallah - ROTH Capital Leland Gershell - Oppenheimer Marc Frahm - Cowen & Company Stephen Willey - Stifel Operator Greetings and welcome to X4 Pharmaceuticals Third Quarter ...

| --- | --- | --- | --- | |--------------------------------------------------------------------------------------------------------------------------------|-------|-------|-------| | | | | | | | | | | | Developing treatments | | | | | designed to have a clear and profound impact for patients with rare diseases, including WHIM syndrome and uncommon cancers | | | | | September 2021 Investor Deck | | | | | | | | | Forward-Looking Statements 2 This presentation contains forward-looking statements within the mea ...

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q2 2021 Earnings Conference Call August 3, 2021 8:30 AM ET Company Participants Carey Gallant - Investor Relations, LifeSci Advisors Paula Ragan - Chief Executive Officer Adam Mostafa - Chief Financial Officer Art Taveras - Chief Scientific Officer Conference Call Participants Trevor Allred - Oppenheimer RK - H.C. Wainwright Zegbeh Jallah - ROTH Capital Partners Mayank Mamtani - B. Riley Financial Ben Shim - Canaccord. Operator Greetings, and welcome to X4 Pharmaceutic ...

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q1 2021 Earnings Conference Call May 6, 2021 8:30 AM ET Company Participants Daniel Ferry - LifeSci Advisors Paula Ragan - CEO Adam Mostafa - CFO Art Taveras - Chief Scientific Officer Diego Cadavid - Chief Medical Officer Conference Call Participants Stephen Willey - Stifel Marc Frahm - Cowen Swayampakula Ramakanth - H.C. Wainwright Sahil Kazmi - B. Riley FBR Arlinda Lee - Canaccord Genuity Operator Greetings and welcome to X4 Pharmaceuticals First Quarter Financial a ...